Merrimack Pharmaceuticals (United States)
- World rank, all time
- #19,471 of 34,923
- Rank in United States
- #4,039 of 7,310
- Research works
- 228 ▼ 88% vs 2018-21
- Citations
- 5.9k 25.8 per fractional work
- Top-10% rate
- 8.2% all institutions 10.0%
- vs its own fields
- 1.01× 1.00× is exactly expected
- Open access
- 23% world 40%
- International
- 12% world 18%
Which fields of science does Merrimack Pharmaceuticals (United States) work in?
In all years, 48% of research at Merrimack Pharmaceuticals (United States) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (5%). It does 2.0× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 22 fields, with their numbers
- Health Sciences10947.9%
- Medicine10847.3%
- Health Professions10.3%
- Nursing10.3%
- Life Sciences7332.0%
- Physical Sciences3917.2%
- Engineering114.8%
- Materials Science104.3%
- Computer Science73.3%
- Chemistry41.8%
- Physics and Astronomy21.1%
- Environmental Science20.7%
- Mathematics10.6%
- Chemical Engineering10.5%
- Earth and Planetary Sciences00.1%
- Social Sciences72.9%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.1×. Every wedge is a field page.
All 7 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology7.13×2 works
- Medicine1.50×1 works
- Social Sciences1.32×1 works
- Health Professions1.15×0 works
- Environmental Science0.77×0 works
- Materials Science0.54×0 works
- Engineering0.51×0 works
Who are the top researchers at Merrimack Pharmaceuticals (United States)?
Ranked on the quality score, Daryl C. Drummond, Ashish V. Kalra and Jonathan B. Fitzgerald lead among researchers whose main affiliation is Merrimack Pharmaceuticals (United States).
- 1
Daryl C. Drummond
United States · #113,818 worldwide 10k citations · 205 works
- 2
Ashish V. Kalra
United States · #114,636 worldwide 2.3k citations · 100 works
- 3
Jonathan B. Fitzgerald
United States · #145,841 worldwide 3.4k citations · 148 works
- 4
Alexey A. Lugovskoy
United States · #147,035 worldwide 8k citations · 118 works
- 5
Bart S. Hendriks
United States · #291,839 worldwide 3k citations · 115 works
- 6
Birgit Schoeberl
United States · #312,357 worldwide 4.8k citations · 138 works
- 7
Jeffrey D. Kearns
United States · #320,449 worldwide 2.3k citations · 68 works
- 8
Violette B. Paragas
United States · #390,993 worldwide 2.6k citations · 55 works
- 9
Elena Geretti
United States · #519,829 worldwide 1.9k citations · 70 works
- 10
Jason Baum
United States · #540,579 worldwide 910 citations · 90 works
Which keywords describe research at Merrimack Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Glycosylation, Monoclonal Antibodies, Breast Cancer, Therapeutic Antibodies, Antibody Engineering, Fc Receptors and Monoclonal Antibody.
- EGFR Mutations
- PET Imaging
- Virtual Screening
- Medicinal Chemistry
- Pharmacokinetics
- Glycans
- Polymeric Nanoparticles
- Surface Engineering
- Metastatic Breast Cancer
- Metabolism
- Clinical Trials
- Nanoparticles
- Immunotherapy
- Cancer Therapy
- EGFR
- Trastuzumab
- Monoclonal Antibody
- Antibody Engineering
- Breast Cancer
- Glycosylation
- Chemotherapy
- Monoclonal Antibodies
- Therapeutic Antibodies
- Fc Receptors
- Receptor tyrosine kinases
- Cancer
- HER2
- Targeted Therapy
- Tumor Targeting
- Tumor Microenvironment
- Magnetic Nanoparticles
- Biomedical Applications
- Drug Delivery
- Nanocarriers
- Immune System
- Mucins
- Signaling
- Molecular Docking
- Immunity
- ALK Inhibitors
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy36▲ 22×14 topics
- Glycosylation32▲ 64×3 topics
- Monoclonal Antibodies25▲ 77×3 topics
- Breast Cancer25▲ 39×6 topics
- Therapeutic Antibodies25▲ 84×2 topics
- Antibody Engineering23▲ 102×1 topic
- Fc Receptors23▲ 102×1 topic
- Monoclonal Antibody22▲ 142×2 topics
- Receptor tyrosine kinases22▲ 222×2 topics
- Trastuzumab22▲ 222×2 topics
- Cancer21▲ 6.6×24 topics
- EGFR21▲ 301×1 topic
- HER221▲ 301×1 topic
- Cancer Therapy16▲ 11×12 topics
- Targeted Therapy15▲ 30×4 topics
- Immunotherapy15▲ 10×9 topics
- Tumor Targeting15▲ 48×3 topics
- Nanoparticles13▲ 4.3×7 topics
- Tumor Microenvironment10▲ 13×7 topics
- Clinical Trials10▲ 7.2×7 topics
- Magnetic Nanoparticles8▲ 35×2 topics
- Metabolism8▲ 5.5×6 topics
- Biomedical Applications8▲ 3.3×4 topics
- Metastatic Breast Cancer8▲ 52×2 topics
- Drug Delivery8▲ 7.2×3 topics
- Surface Engineering8▲ 30×2 topics
- Nanocarriers8▲ 77×1 topic
- Polymeric Nanoparticles8▲ 77×1 topic
- Immune System8▲ 10.0×2 topics
- Glycans7▲ 40×1 topic
- Mucins7▲ 40×1 topic
- Pharmacokinetics7▲ 11×3 topics
- Signaling7▲ 25×4 topics
- Medicinal Chemistry6▲ 7.3×4 topics
- Molecular Docking6▲ 18×1 topic
- Virtual Screening6▲ 37×1 topic
- Immunity6▲ 7.3×5 topics
- PET Imaging6▲ 11×4 topics
- ALK Inhibitors5▲ 42×1 topic
- EGFR Mutations5▲ 42×1 topic
Which research topics does Merrimack Pharmaceuticals (United States) publish most on?
By volume in 2022-now: CAR-T cell therapy research, Advanced biosensing and bioanalysis techniques, Lipid Membrane Structure and Behavior and RNA Interference and Gene Delivery.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 0 works
- 2 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
- 3 Lipid Membrane Structure and Behavior Molecular Biology 0 works
- 4 RNA Interference and Gene Delivery Molecular Biology 0 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 6 Cancer Genomics and Diagnostics Cancer Research 0 works
- 7 African Studies and Geopolitics Anthropology 0 works
- 8 Healthcare and Environmental Waste Management Public Health, Environmental and Occupational Health 0 works
- 9 Multiculturalism, Politics, Migration, Gender Political Science and International Relations 0 works
- 10 Political and Social Issues Political Science and International Relations 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Merrimack Pharmaceuticals (United States)'s research output changed?
Output in 2022-2025 was 88% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Merrimack Pharmaceuticals (United States) as a percentage of every work published that year, 0.000055% in 2022.
Fractional works of Merrimack Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- National Bureau of Economic Research
- World Wide Web Consortium
- Biogen (United States)
- Draper Laboratory
- Cambridge Health Alliance
- Harvard Global Health Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Merrimack Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
